Aspects of efficacy, safety and adherence to antihypertensive therapy with single pill combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in...

por Irina E. Chazova, Tamila V. Martynyuk, Oleg V. Rodnenkov, Shurat B. Gorieva, Anatolii N. Rogoza, Mikhail V. Arkhipov, Yury I. Grinshtein, Olga D. Ostroumova, Albert S. Galyavich, Oxana P. Rotar’, Larisa A. Khaisheva, Tatiana R. Kameneva
Publicado 2021

Management of patients with arterial hypertension and atrial fibrillation

por Irina E. Chazova, Sergei P. Golitsyn, Juliya V. Zhernakova, Ekaterina A. Zheleznova, Ekaterina S. Kropacheva, Nikolai Iu. Mironov, Marina V. Kostiukevich, Lada Iu. Laiovich, Madina D. Utsumueva, Iuliia A. Iuricheva, Alexander Yu. Litvin, Evgeniia M. Elfimova, Anatolii N. Rogoza, Elizaveta P. Panchenko
Publicado 2021

Factors Associated with Anxiety and Depressive Symptoms in 2775 Patients with Arterial Hypertension and Coronary Heart Disease: Results from the COMETA Multicenter Study

por Nana Pogosova, Sergey Boytsov, Dirk De Bacquer, Olga Sokolova, Aza Ausheva, Alexander Kursakov, Hugo Saner
Publicado 2021

Left ventricular geometric sportsmen power sports heavyweight with arterial hypertension

por Alexander B. Miroshnikov, Andrey V. Smolensky
Publicado 2020

Heart lesions in individuals with arterial hypertension of various risk levels: the possibility of diagnosis and treatment

por Anatolii N. Britov, Elena M. Platonova, Nina A. Eliseeva
Publicado 2020

Clinical guidelines on arterial hypertension diagnosis, treatment and prevention in children and adolescents

por A. A. Aleksandrov, O. A. Kisliak, I. V. Leontyeva
Publicado 2020

Contrast-associated acute kidney injury in patients with arterial hypertension and stable coronary artery disease

por Olga Iu. Mironova, Viktor V. Fomin
Publicado 2020

Obesity as a risk factor of contrast-induced acute kidney injury in patients with arterial hypertension and stable coronary artery disease

por Olga Iu. Mironova, Olga A. Sivakova, Viktor V. Fomin
Publicado 2021

Contrast-associated acute kidney injury in patients with arterial hypertension and coronary artery disease and its long-term prognosis

por Olga Iu. Mironova, Viktor V. Fomin
Publicado 2021

Intratracheal instillation of ethyl pyruvate nanoparticles prevents the development of shunt-flow-induced pulmonary arterial hypertension in a rat model

por Liu K, Zhang XQ, Cao GQ, Liu YJ, Liu CZ, Sun HR, Pang XY
Publicado 2016

Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3...

por Irina E. Chazova, Tamila V. Martynyuk, Oleg V. Rodnenkov, Shurat B. Gorieva, Anatolii N. Rogoza, Mikhail V. Arkhipov, Yury I. Grinshtein, Olga D. Ostroumova, Albert S. Galiavich, Oxana P. Rotar’, Larisa A. Khaisheva, Tatiana R. Kameneva
Publicado 2020

Fibrinolytic markers could be useful predictors of severity in patients with pulmonary arterial hypertension: a retrospective study

por Makoto Shoji, Taiju Matsui, Hideaki Tanaka, Kosuke Nomura, Hiroaki Tsujita, Yusuke Kodama, Shinji Koba, Youichi Kobayashi, Toshiro Shinke
Publicado 2021

MANAGEMENT OF HYPERTENSIVE PDA

por Khushal Khan Khattak, Maad Ullah, Abdul Malik Sheikh, Asma Kanwal, Sajid Ali Shah, Noor -Un- Nisa
Publicado 2020

Right Ventricular Diastolic Performance in Patients With Chronic Thromboembolic Pulmonary Hypertension Assessed by Echocardiography

por Hong Meng, Wu Song, Sheng Liu, David Hsi, Lin-Yuan Wan, Hui Li, Shan-shan Zheng, Zhi-wei Wang, Rong Ren, Wei-xian Yang
Publicado 2021

Mechanical circulatory support during high-risk percutaneous coronary intervention in a young male patient

por Artur Pawlik, Paweł Kleczyński, Dariusz Dudek, Artur Dziewierz, Stanisław Bartuś
Publicado 2020